These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32950451)

  • 61. Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?
    Ruberg FL; Miller EJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):162-4. PubMed ID: 23512778
    [No Abstract]   [Full Text] [Related]  

  • 62. Echocardiographic tools for prognostic stratification in transthyretin cardiac amyloidosis: a new arrow in the quiver.
    Citro R; Silverio A; Bellino M
    Eur Heart J Cardiovasc Imaging; 2024 Mar; 25(4):480-481. PubMed ID: 38279943
    [No Abstract]   [Full Text] [Related]  

  • 63. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors.
    Barge-Caballero G; Vázquez-García R; Barge-Caballero E; Couto-Mallón D; Paniagua-Martín MJ; Barriales-Villa R; Piñón-Esteban P; Bouzas-Mosquera A; Pombo-Otero J; Debén-Ariznavarreta G; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Med Clin (Barc); 2021 Apr; 156(8):369-378. PubMed ID: 32591181
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin to creatinine ratio and need for further evidence generation.
    Khan MS; Sperry BW; Butler J
    Eur J Heart Fail; 2024 Jan; 26(1):74-76. PubMed ID: 38191996
    [No Abstract]   [Full Text] [Related]  

  • 65. Diagnosis of amyloid neuropathy.
    Kapoor M; Rossor AM; Jaunmuktane Z; Lunn MPT; Reilly MM
    Pract Neurol; 2019 Jun; 19(3):250-258. PubMed ID: 30598431
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
    Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
    Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
    [No Abstract]   [Full Text] [Related]  

  • 67. Response: Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
    Henein MY; Lindqvist P
    Amyloid; 2018 Jun; 25(2):136. PubMed ID: 29529882
    [No Abstract]   [Full Text] [Related]  

  • 68. Cardiac amyloidosis.
    Quarta CC; Kruger JL; Falk RH
    Circulation; 2012 Sep; 126(12):e178-82. PubMed ID: 22988049
    [No Abstract]   [Full Text] [Related]  

  • 69. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
    Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
    Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
    [No Abstract]   [Full Text] [Related]  

  • 70. Different NT-proBNP circulating levels for different types of cardiac amyloidosis.
    Perfetto F; Bergesio F; Grifoni E; Fabbri A; Ciuti G; Frusconi S; Angelotti P; Spini V; Cappelli F
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):810-7. PubMed ID: 26765991
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantifying is believing: Techniques for evaluating transthyretin cardiac amyloidosis burden for expanded clinical applications.
    Miller RJH; Fine N
    J Nucl Cardiol; 2022 Dec; 29(6):3111-3114. PubMed ID: 34921352
    [No Abstract]   [Full Text] [Related]  

  • 72. Spontaneous intramyocardial haemorrhage in a patient with wild-type transthyretin cardiac amyloidosis.
    Liu C; Witschey WRT; Santangeli P; Han Y
    Eur Heart J; 2021 Dec; 42(48):4929. PubMed ID: 33346807
    [No Abstract]   [Full Text] [Related]  

  • 73. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
    Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
    [No Abstract]   [Full Text] [Related]  

  • 74. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amyloidosis Imaging: Prime Time Biomarker Yet Still a Moving Target.
    Blankstein R; Shaw L; Chandrashekhar Y
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1392-1394. PubMed ID: 32498923
    [No Abstract]   [Full Text] [Related]  

  • 76. New challenges in the management of patients with transthyretin cardiac amyloidosis: beyond oral anticoagulation.
    de Frutos F; Gonzalez-Lopez E
    Rev Esp Cardiol (Engl Ed); 2023 Jul; 76(7):494-496. PubMed ID: 36716993
    [No Abstract]   [Full Text] [Related]  

  • 77. [Transthyretin-related hereditary amyloidosis].
    Vionnet J; Pascual M; Kuntzer T; Yerly P; Moradpour D
    Rev Med Suisse; 2016 Aug; 12(528):1434-1440. PubMed ID: 28675284
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
    Hendren NS; Roth LR; Grodin JL
    Curr Heart Fail Rep; 2020 Jun; 17(3):77-83. PubMed ID: 32356182
    [TBL] [Abstract][Full Text] [Related]  

  • 79. "SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series" comment.
    Patoulias D; Papadopoulos C; Doumas M
    Intern Emerg Med; 2022 Aug; 17(5):1553-1554. PubMed ID: 35334061
    [No Abstract]   [Full Text] [Related]  

  • 80. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
    Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
    J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.